Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine

Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis. It is a risk marker for cardiovascular events and mortality in patients with cardiometabolic diseases and in population-based studies. Plasma or serum analysis of ADMA may be hampered by pre-analytical sample handling. We valid...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannemann, Juliane, Roskam, Thore I., Eilermann, Ina, Siques, Patricia, Brito, Julio, Böger, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230730/
https://www.ncbi.nlm.nih.gov/pubmed/32283799
http://dx.doi.org/10.3390/jcm9041072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230730/
https://www.ncbi.nlm.nih.gov/pubmed/32283799
http://dx.doi.org/10.3390/jcm9041072

Ejemplares similares